MET vs. RHHBY
MET (MetLife, Inc.) and RHHBY (Roche Holding AG) are both stocks. MET operates in Insurance - Life (Financial Services), while RHHBY operates in Drug Manufacturers - General (Healthcare). Over the past 10 years, MET returned 14.00%/yr vs 8.27%/yr for RHHBY. At a 0.21 correlation, their price movements are largely independent.
Performance
MET vs. RHHBY - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, MET achieves a 14.21% return, which is significantly higher than RHHBY's 3.24% return. Over the past 10 years, MET has outperformed RHHBY with an annualized return of 14.00%, while RHHBY has yielded a comparatively lower 8.27% annualized return.
MET
- 1D
- 1.44%
- 1M
- 13.78%
- YTD
- 14.21%
- 6M
- 9.74%
- 1Y
- 15.84%
- 3Y*
- 20.82%
- 5Y*
- 10.04%
- 10Y*
- 14.00%
RHHBY
- 1D
- 0.58%
- 1M
- 0.76%
- YTD
- 3.24%
- 6M
- 6.39%
- 1Y
- 26.91%
- 3Y*
- 13.95%
- 5Y*
- 5.12%
- 10Y*
- 8.27%
MET vs. RHHBY - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
MET MetLife, Inc. | 14.21% | -0.80% | 27.68% | -5.49% | 19.23% | 37.43% | -3.42% | 28.84% | -15.77% | 21.67% |
RHHBY Roche Holding AG | 3.24% | 52.86% | 0.23% | -4.02% | -22.21% | 20.20% | 9.94% | 33.47% | 2.16% | 14.32% |
Correlation
The correlation between MET and RHHBY is 0.21, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.21 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.18 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.20 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.16 |
Correlation (All Time) Calculated using the full available price history since Jan 2, 2001 | 0.21 |
Fundamentals
MET:
$7.21
RHHBY:
CHF 5.42
MET:
12.33
RHHBY:
7.59
MET:
0.58
RHHBY:
1.23
MET:
$76.95B
RHHBY:
CHF 107.65B
MET:
$14.75B
RHHBY:
CHF 79.28B
MET:
$4.11B
RHHBY:
CHF 31.01B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
MET vs. RHHBY — Risk / Return Rank
MET
RHHBY
MET vs. RHHBY - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for MetLife, Inc. (MET) and Roche Holding AG (RHHBY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| MET | RHHBY | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.30 | ||
| Sortino ratioReturn per unit of downside risk | -0.59 | ||
| Omega ratioGain probability vs. loss probability | 1.13 | 1.20 | -0.06 |
| Calmar ratioReturn relative to maximum drawdown | 0.91 | 1.40 | -0.48 |
| Martin ratioReturn relative to average drawdown | 2.48 | 3.39 | -0.92 |
Loading charts...
Drawdowns
MET vs. RHHBY - Drawdown Comparison
The maximum MET drawdown since its inception was -82.37%, which is greater than RHHBY's maximum drawdown of -45.73%. Use the drawdown chart below to compare losses from any high point for MET and RHHBY.
Loading charts...
Drawdown Indicators
| MET | RHHBY | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -82.37% | -45.73% | -36.64% |
Max Drawdown (1Y)Largest decline over 1 year | -17.46% | -19.38% | +1.92% |
Max Drawdown (3Y)Largest decline over 3 years | -21.97% | -23.46% | +1.49% |
Max Drawdown (5Y)Largest decline over 5 years | -35.09% | -40.88% | +5.79% |
Max Drawdown (10Y)Largest decline over 10 years | -55.16% | -40.88% | -14.28% |
Current DrawdownCurrent decline from peak | 0.00% | -12.12% | +12.12% |
Average DrawdownAverage peak-to-trough decline | -17.62% | -12.84% | -4.78% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 6.42% | 8.09% | -1.67% |
Volatility
MET vs. RHHBY - Volatility Comparison
The current volatility for MetLife, Inc. (MET) is 6.17%, while Roche Holding AG (RHHBY) has a volatility of 8.27%. This indicates that MET experiences smaller price fluctuations and is considered to be less risky than RHHBY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| MET | RHHBY | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.17% | 8.27% | -2.10% |
Volatility (6M)Calculated over the trailing 6-month period | 17.44% | 18.31% | -0.87% |
Volatility (1Y)Calculated over the trailing 1-year period | 23.16% | 27.49% | -4.33% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 25.72% | 23.34% | +2.38% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 30.70% | 22.55% | +8.15% |
Dividends
MET vs. RHHBY - Dividend Comparison
MET's dividend yield for the trailing twelve months is around 2.58%, less than RHHBY's 3.00% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
MET MetLife, Inc. | 2.58% | 2.85% | 2.63% | 3.12% | 2.74% | 3.04% | 3.88% | 3.41% | 4.04% | 14.52% | 2.92% | 3.06% |
RHHBY Roche Holding AG | 3.00% | 2.69% | 3.87% | 3.55% | 3.23% | 1.57% | 1.66% | 1.70% | 3.58% | 3.25% | 3.57% | 2.91% |
Financials
MET vs. RHHBY - Financials Comparison
This section allows you to compare key financial metrics between MetLife, Inc. and Roche Holding AG. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
MET vs. RHHBY - Profitability Comparison
MET - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, MetLife, Inc. reported a gross profit of 0.00 and revenue of 19.07B. Therefore, the gross margin over that period was 0.0%.
RHHBY - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Roche Holding AG reported a gross profit of 21.75B and revenue of 30.32B. Therefore, the gross margin over that period was 71.7%.
MET - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, MetLife, Inc. reported an operating income of 0.00 and revenue of 19.07B, resulting in an operating margin of 0.0%.
RHHBY - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Roche Holding AG reported an operating income of 7.05B and revenue of 30.32B, resulting in an operating margin of 23.2%.
MET - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, MetLife, Inc. reported a net income of 1.19B and revenue of 19.07B, resulting in a net margin of 6.2%.
RHHBY - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Roche Holding AG reported a net income of 5.42B and revenue of 30.32B, resulting in a net margin of 17.9%.
Frequently Asked Questions
MET and RHHBY have a correlation of 0.21, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
RHHBY has higher volatility (8.27%) compared to MET (6.17%). In terms of maximum drawdown, MET dropped -82.37% vs RHHBY's -45.73%.
RHHBY currently has the higher Sharpe Ratio (0.99 vs 0.69), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for MET and RHHBY
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer